PathwaysGI
Ann Arbor, US · Founded 2022 · Delaware corporation
Pathways GI develops AI-based methods for clinical decision support in gastroenterology, with a focus on inflammatory bowel disease (IBD). The company applies computational medicine and clinical trial design expertise to healthcare applications.
Founders & leadership
PathwaysGI was founded in 2022 by Ryan Stidham and Kayvan Najarian.
RS
Ryan StidhamCMO / Co-Founder
KN
Kayvan NajarianCo-Founder
KW
Kevin WittrupCEO / Co-Founder
PB
Prem BodagalaNamed on SEC filing
SB
Steve BollingNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$350K disclosed across 1 round · 2023
▶$350KraisedMar 2023 · 2 investors · Other Health CareRule 506(b)
▶$350KraisedMar 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan StidhamExecutive Officer, Director
- Kevin WittrupExecutive Officer, Director
- Prem BodagalaDirector
- Kayvan NajarianExecutive Officer
- Steve BollingDirector
- Offering amount
- $500K
- Amount sold
- $350K
- Minimum investment
- $50K
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does PathwaysGI do?
- Pathways GI develops AI-based methods for clinical decision support in gastroenterology, with a focus on inflammatory bowel disease (IBD). The company applies computational medicine and clinical trial design expertise to healthcare applications.
- Who founded PathwaysGI?
- PathwaysGI was founded by Ryan Stidham, Kayvan Najarian in 2022.
- How much funding has PathwaysGI raised?
- PathwaysGI has disclosed $350K raised across 1 round.
- Where is PathwaysGI headquartered?
- PathwaysGI is headquartered in Ann Arbor, US.